Use of SGLT-2 Inhibitors in Patients with Advanced Renal Disease

Use of SGLT-2 Inhibitors in Patients with Advanced Renal Disease

Speaker: Thomas Mavrakanas, MD, MSc, FRCPC, FASN

Associate Professor of Medicine, McGill University

Attending Physician, Division of Nephrology, Department of Medicine, McGill University Health Centre

Scientist, Research Institute, McGill University Health Centre

Member, Graduate Program in Clinical and Translational Research, McGill University

Director, Cardiorenal and Nephrology Research Fellowships, McGill University

Educational Objectives:

1. Clinical evidence with SGLT-2 inhibitors in patients with moderate and advanced CKD
2.  Pharmacokinetics of SGLT-2 inhibitors in hemodialysis
3. Clinical trials with SGLT-2 inhibitors in patients with end-stage renal disease

Join the Medical Grand Rounds on Microsoft Teams meeting.
Or call in (audio only) NEW: +1 438-799-0762, 502095193# Canada, Montreal, Phone Conference ID: 502 095 193#

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Some Rounds were video recorded.

Full JGH Medical Grand Rounds Schedule